Cargando…
Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1994
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968870/ https://www.ncbi.nlm.nih.gov/pubmed/8123501 |
| _version_ | 1782134834853838848 |
|---|---|
| author | Cohen, I. Rosen, D. J. Altaras, M. Beyth, Y. Shapira, J. Yigael, D. |
| author_facet | Cohen, I. Rosen, D. J. Altaras, M. Beyth, Y. Shapira, J. Yigael, D. |
| author_sort | Cohen, I. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1968870 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1994 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19688702009-09-10 Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. Cohen, I. Rosen, D. J. Altaras, M. Beyth, Y. Shapira, J. Yigael, D. Br J Cancer Letter Nature Publishing Group 1994-03 /pmc/articles/PMC1968870/ /pubmed/8123501 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Cohen, I. Rosen, D. J. Altaras, M. Beyth, Y. Shapira, J. Yigael, D. Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| title | Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| title_full | Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| title_fullStr | Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| title_full_unstemmed | Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| title_short | Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| title_sort | tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968870/ https://www.ncbi.nlm.nih.gov/pubmed/8123501 |
| work_keys_str_mv | AT coheni tamoxifentreatmentinpremenopausalbreastcancerpatientsmaybeassociatedwithovarianoverstimulationcysticformationsandfibroidovergrowth AT rosendj tamoxifentreatmentinpremenopausalbreastcancerpatientsmaybeassociatedwithovarianoverstimulationcysticformationsandfibroidovergrowth AT altarasm tamoxifentreatmentinpremenopausalbreastcancerpatientsmaybeassociatedwithovarianoverstimulationcysticformationsandfibroidovergrowth AT beythy tamoxifentreatmentinpremenopausalbreastcancerpatientsmaybeassociatedwithovarianoverstimulationcysticformationsandfibroidovergrowth AT shapiraj tamoxifentreatmentinpremenopausalbreastcancerpatientsmaybeassociatedwithovarianoverstimulationcysticformationsandfibroidovergrowth AT yigaeld tamoxifentreatmentinpremenopausalbreastcancerpatientsmaybeassociatedwithovarianoverstimulationcysticformationsandfibroidovergrowth |